)
Documentation is one of the heaviest burdens in veterinary practice. Notes get written between appointments, after hours, and at home. It is the part of the job that follows you out of the building.
CoVet was built to take that off your plate. Tens of thousands of veterinary professionals across six continents now use it every day, in more than 100 languages, to capture and organise information across a patient's care.
Today we are sharing some exciting news. CoVet has been acquired by IDEXX a global leader in pet healthcare innovation.
What changes for CoVet customers today
Nothing.
You log in the same way. The product works exactly as it does now. Your notes and your history are where you left them. CoVet keeps working with the practice management systems you already use, IDEXX or not. You get support the same way you always have, from the same team.
There is no action for you to take.
Why IDEXX
Every conversation we had about this came back to the same place. There are a lot of veterinary teams we have not reached yet, and they are doing this the hard way in the meantime. The same late notes, the same evenings lost, the same slow erosion of why people joined this profession. We have already built the answer to that. Getting it to them sooner mattered more to us than getting there on our own.
Our co-founder and Chief Veterinary Officer, Dr. Mike Mossop, helped build CoVet around the challenges he experienced in veterinary practice. That perspective helped shape what we looked for in a partner.
“We built CoVet to help veterinary teams spend less time on documentation and more time on the work they love. In IDEXX, we saw a partner that understands veterinary practice and shares our commitment to supporting the people in it. Joining forces gives us the opportunity to bring CoVet to more teams and keep improving what we can do for them.”
CoVet was built to give veterinary teams more time for the work they love. IDEXX’s global presence and longstanding relationships across the profession give us an opportunity to bring that support to more practices, while continuing to build on what CoVet can do for the teams already using it.
What we can build together
This partnership gives us more support to keep improving CoVet, develop new capabilities and reach more veterinary teams around the world.
There are clinics in countries we do not serve yet, working in languages we do not support yet, carrying exactly the same documentation burden as the clinics that found us three years ago. IDEXX’s global presence gives us the opportunity to bring CoVet to more veterinary teams and better support the needs of practices in different countries.”
It also means we can keep building at the speed our users have come to expect, with more behind us. More countries. More languages. Deeper support for enterprise groups and academic programs. More integrations and partnerships across the veterinary software industry, not fewer.
Documentation was where we started. It was never meant to be the whole of what this becomes, and our co-founder and CEO, Yannick Bloem, has been saying so since long before this deal existed.
“From the beginning, our mission has been to use technology to give veterinary professionals more time back, for their patients and for themselves. We started with clinical documentation, but the opportunity is far greater. AI has the potential to change the day-to-day experience of practicing veterinary medicine, to the benefit of more pets. With IDEXX, we can bring that to veterinary teams around the world.”
Thank you
Our work is not all about software. Our co-founder and COO, Mike Parent, puts it where it belongs.
“What I'm most proud of is how much our team cares about the people we're building for, and how they turn that care into tools that make a real difference in a veterinary team's day. Joining IDEXX gives us the opportunity to bring that work to more practices and go further with what we can build.”
To every clinic that trusted us early, told us what was broken, and stayed while we fixed it: this happened because of you.
The work continues, now at greater scale.
About the Author
)
)
